Profit & Loss

PHARMAIDS PHARMACEUTICALS LTD.

NSE : NABSE : 524572ISIN CODE : INE117D01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE52.000 (0 %)
PREV CLOSE ( ) 52.00
OPEN PRICE ( ) 51.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3653
TODAY'S LOW / HIGH ( )51.20 53.04
52 WK LOW / HIGH ( ) 19.6979.23
NSE
This Company is not listed in NSE
Select year
( in Million)
Particulars
Mar 2023
Mar 2022
INCOME :
  
  
Gross Sales
39.39
     Sales
39.39
     Job Work/ Contract Receipts
     Processing Charges / Service Income
     Revenue from property development
     Other Operational Income
0.00
0.00
Less: Excise Duty
Net Sales
39.39
EXPENDITURE :
Increase/Decrease in Stock
8.88
-5.19
Raw Material Consumed
40.90
     Opening Raw Materials
     Purchases Raw Materials
     Closing Raw Materials
     Other Direct Purchases / Brought in cost
40.90
     Other raw material cost
0.00
0.00
Power & Fuel Cost
0.01
     Electricity & Power
0.01
     Oil, Fuel & Natural gas
0.00
0.00
     Coals etc
0.00
0.00
     Other power & fuel
0.00
0.00
Employee Cost
11.31
0.44
     Salaries, Wages & Bonus
11.31
0.44
     Contributions to EPF & Pension Funds
     Workmen and Staff Welfare Expenses
     Other Employees Cost
0.00
0.00
Other Manufacturing Expenses
     Sub-contracted / Out sourced services
     Processing Charges
     Repairs and Maintenance
     Packing Material Consumed
     Other Mfg Exp
0.00
0.00
General and Administration Expenses
8.38
1.75
     Rent , Rates & Taxes
2.52
0.12
     Insurance
     Printing and stationery
0.16
     Professional and legal fees
3.66
0.49
     Traveling and conveyance
0.45
     Other Administration
1.60
1.15
Selling and Distribution Expenses
0.06
0.11
     Advertisement & Sales Promotion
0.06
0.11
     Sales Commissions & Incentives
     Freight and Forwarding
     Handling and Clearing Charges
0.00
0.00
     Other Selling Expenses
0.00
0.00
Miscellaneous Expenses
70.23
     Bad debts /advances written off
66.57
     Provision for doubtful debts
     Losson disposal of fixed assets(net)
     Losson foreign exchange fluctuations
     Losson sale of non-trade current investments
     Other Miscellaneous Expenses
3.66
0.00
Less: Expenses Capitalised
Total Expenditure
98.86
38.02
Operating Profit (Excl OI)
-98.86
1.37
Other Income
0.15
     Interest Received
     Dividend Received
     Profit on sale of Fixed Assets
     Profits on sale of Investments
     Provision Written Back
     Foreign Exchange Gains
     Others
0.00
0.15
Operating Profit
-98.86
1.52
Interest
0.05
0.03
     InterestonDebenture / Bonds
     Interest on Term Loan
     Intereston Fixed deposits
     Bank Charges etc
0.03
0.03
     Other Interest
0.01
0.00
PBDT
-98.91
1.49
Depreciation
0.17
0.09
Profit Before Taxation & Exceptional Items
-99.08
1.40
Exceptional Income / Expenses
Profit Before Tax
-99.08
1.40
Provision for Tax
-23.52
-0.05
     Current Income Tax
     Deferred Tax
-23.52
-0.05
     Other taxes
0.00
0.00
Profit After Tax
-75.56
1.45
Extra items
0.00
0.00
Minority Interest
Share of Associate
Other Consolidated Items
0.35
Consolidated Net Profit
-75.21
1.45
Adjustments to PAT
Profit Balance B/F
-23.33
-24.78
Appropriations
-98.54
-23.33
     General Reserves
     Proposed Equity Dividend
     Corporate dividend tax
     Other Appropriation
Equity Dividend %
Earnings Per Share
-3.51
0.14
Adjusted EPS
-3.51
0.14

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.